510(k) K010891

MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01 by Digene Corp. — Product Code LSK

K010891 is an FDA 510(k) premarket notification submitted by Digene Corp. for the device "MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01". The FDA issued a decision of Substantially Equivalent on September 25, 2001. The device falls under product code LSK (Dna-Reagents, Chlamydia), a Class I device regulated under 21 CFR 866.3120. Digene Corp. has at least 8 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 25, 2001
Date Received
March 26, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Dna-Reagents, Chlamydia
Device Class
Class I
Regulation Number
866.3120
Review Panel
MI
Submission Type